[1] Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74Á108.
[2] Pirozynski M. 100 years of lung cancer. Respir Med 2006; 100:2073Á2084.
[3] Giaccone G. Clinical impact of novel treatment strategies. Oncogene 2002;21:6970Á6981.
[4] Jassem J. The role of radiotherapy in lung cancer: where is the evidence? Radiother Oncol 2007;83:203Á213.
[5] Lawrence TS, Ten Haken RK, Giaccia A. Principles of radiation oncology. In: Devita VT Jr, Lawrence TS, Rosen- berg SA, editors. Cancer: Principles and practice of oncology. 8 th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008: p 307Á337.
[6] Riley PA. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Radiat Biol 1994;65:27Á33.
[7] Schock BC, Young IS, Brown V, Fitch PS, Shields MD, Ennis M. Antioxidants and oxidative stress in BAL fluid of atopic asthmatic children. Pediatr Res 2003;53:375Á381.
[8] Starosta V, Rietschel E, Paul K, Baumann U, Griese M. Oxidative changes of bronchoalveolar proteins in cystic fibrosis. Chest 2006;129:431Á437.
[9] Emad A, Emad V. Elevated levels of MCP-1, MIP-a and MIP-1 b in the bronchoalveolar lavage (BAL) fluid of patients with mustard gas-induced pulmonary fibrosis. Toxicology 2007;240:60Á69.
[10] Drost EM, Skwarski KM, Sauleda J, Soler N, Roca J, Agusti A, MacNee W. Oxidative stress and airway inflamma- tion in severe exacerbations of COPD. Thorax 2005;60: 293Á300.
[11] Mudway IS, Stenfors N, Blomberg A, Helleday R, Dunster C, Marklund SL, Frew AJ, Sandstr  ̈ m T, Kelly FJ. Differences in basal airway antioxidant concentrations are not predictive of individual responsiveness to ozone: a comparison of healthy and mild asthmatic subjects. Free Radic Biol Med 2001;31:962Á974.
[12] Behndig AF, Mudway IS, Brown JL, Stenfors N, Helleday R, Duggan ST, Wilson SJ, Boman C, Cassee FR, Frew AJ, Kelly FJ, Sandstr  ̈ m T, Blomberg A. Airway antioxidant and inflammatory responses to diesel exhaust exposure in healthy humans. Eur Respir J 2006;27:359Á365.
[13] Melloni B, Lefebvre MA, Bonnaud F, Vergnen `gre A, Grossin L, Rigaud M, Cantin A. Antioxidant activity in bronchoalveolar lavage fluid from patients with lung cancer. Am J Respir Crit Care Med 1996;154:1706Á1711.
[14] Beinert T, Binder D, Oehm C, Ziemer S, Priem F, Schweigert M, Stuschke M, Fleischhacker M, Siebert G, Mergenthaler HG, Werner TG, Sezer O, Possinger K. Increased levels of vascular endothelial growth factor in bronchoalveolar lavage of patients with bronchial carcinoma effect of tumour activity and oxidative stress due to radio-chemotherapy? Eur J Med Res 1999;4:328Á334.
[15] Beinert T, Binder D, Oehm C, Ziemer S, Priem F, Stuschke M, Schweigert M, Siebert G, Mergenthaler HG, Schmid P, Fleischhacker M, Possinger K. Further evidence for oxidant- induced vascular endothelial growth factor up-regulation in the bronchoalveolar lavage fluid of lung cancer patients undergoing radio-chemotherapy. J Cancer Res Clin Oncol 2000;126:352Á356.
[16] Barthelemy-Brichant N, Bosqu  ́e L, Cataldo D, Corhay JL, Gustin M, Seidel L, Thiry A, Ghaye B, Nizet M, Albert A, Deneufbourg JM, Bartsch P, Nusgens B. Increased IL-6 and TGF-b 1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy. Int J Radiat Oncol Biol Phys 2004;58:758Á767.
[17] Cross CE, van der Vliet A, O’Neill CA, Louie S, Halliwell B. Oxidants, antioxidants, and respiratory tract lining fluids. Environ Health Perspect 1994;102:185Á191.
[18] The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer, and other cancers in male smokers. New Engl J Med 1994;330:1029Á1035.
[19] Klech H, Pohl W, editors. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the 
[20] Sokolowsky JW Jr, Burgher LW, Jones FL, Patterson JR, Selecky PA. Guidelines for fiberoptic bronchoscopy in adults. Am Rev Respir Dis 1987;36:1066.
[21] Hu ML. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994;233:380Á385.
[22] Salminen I, Alfthan G. Plasma ascorbic acid preparation and storage for epidemiological studies using TCA precipitation. Clin Biochem 2008;41:723Á727.
[23] Braman RS, Hendrix SA. Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection. Anal Chem 1989;61:2715Á2718.
[24] Kotikoski H, Alajuuma P, Moilanen E, Salmenpera P, Oksala O, Laippala P, Vapaatalo H. Comparison of nitric oxide donors in lowering intraocular pressure in rabbits: role of cyclic GMP. J Ocul Pharmacol Ther 2002;18:11Á23.
[25] Catignani GL, Bieri JG. Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clin Chem 1983;29:708Á712.
[26] Anttolainen M, Valsta LM, Alfthan G, Kleemola P, Salminen I, Tamminen M. Effect of extreme fish consumption on dietary and plasma antioxidant levels and fatty acid composi- tion. Eur J Clin Nutr 1996;50:741Á746.
[27] Porkkala-Sarataho E, Nyyss  ̈ nen K, Salonen JT. Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men. Atherosclerosis 1996;124:83Á94.
[28] Baker MA, Cerniglia GJ, Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 1990; 190:360Á365.
[29] Reznick AZ, Packer L. Oxidative damage to proteins: spectro- photometric method for carbonyl assay. Methods Enzymol 1994;233:357Á363.
[30] Corongiu FP, Lai M, Milia A. Carbon tetrachloride, bromo- trichloromethane and ethanol acute intoxication. New chemical evidence for lipid peroxidation in rat tissue microsomes. Biochem J 1983;212:625Á631.
[31] Bird RP, Draper HH. Comparative studies on different methods of malonaldehyde determination. Methods Enzymol 1984;105:299Á305.
[32] Alanko J, Riutta A, Mucha I, Vapaatalo H, Mets  ̈-Ketel  ̈ T. Modulation of arachidonic acid metabolism by phenols: relation to positions of hydroxyl groups and peroxyl radical scavenging properties. Free Radic Biol Med 1993; 14:19Á25.
[33] Tietz NW, editor. Clinical guide to laboratory tests. 3rd ed. Philadelphia, PA: WB Saunders Company; 1995. p 518Á519.
[34] Doumas BT, Bayse DD, Carter RJ, Peters T Jr, Schaffer R. A candidate reference method for determination of total protein in serum. I. Development and validation. Clin Chem 1981; 27:1642Á1650.
[35] Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207Á214.
[36] LENT SOMA tables. Radiother Oncol 1995;35:17Á60.
[37] Burgaz S, Torun M, Yardim S, Sargin H, Orman MN, Ozdamar NY. Serum carotenoids and uric acid levels in relation to cancer. J Clin Pharm Ther 1996;21:331Á336.
[38] G  ̈ nen  ̧ A, Ozkan Y, Torun M, Sim  ̧ek B. Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J Clin Pharm Ther 2001;26:141Á144.
[39] Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981;78:6858Á6862.
[40] Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett 1995;358:1Á3.
[41] Rozalski R, Gackowski D, Roszkowski K, Foksinski M, Olinski R. The level of 8-hydroxyguanine, a possible repair product of oxidative DNA damage, is higher in urine of cancer patients than in control subjects. Cancer Epidemiol Biomarkers Prev 2002;11:1072Á1075.
[42] Hayden MR, Tyagi SC. Uric a
[43] Metzger IF, Sertorio JTC, Tanus-Santos JE. Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers. Acta Physiol (Oxf) 2006;188: 123Á127.
[44] Bryan NS, Grisham MB. Methods to detect nitric oxide and its metabolites in biological samples. Free Radic Biol Med 2007;43:645Á657.
[45] G  ̈ nen  ̧ A, Erten D, Aslan S, Akinci M, Sim  ̧ek B, Torun M. Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. Cell Biol Int 2006;30:376Á380.
[46] Halliwell B, Gutteridge JMF. Free Radicals in biology and medicine. 4 th ed. Oxford, UK: Oxford University Press; 2007.
[47] Wayner DD, Burton GW, Ingold KU, Locke S. Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. FEBS Lett 1985;187:33Á37.
[48] Erhola M, Nieminen MM, Ojala A, Mets  ̈-Ketel  ̈ T, Kello- kumpu-Lehtinen P, Alho H. Human plasma antioxidant capacity during radiotherapy for lung cancer: a clinical study. J Exp Clin Cancer Res 1998;17:325Á330.
[49] Punnonen K, Ahotupa M, Asaishi K, Hy  ̈ ty M, Kudo R, Punnonen R. Antioxidant enzyme activities and oxidative stress in human breast cancer. J. Cancer Res Clin Oncol 1994;120:374Á377.
[50] Du  ̈ rken M, Herrnring C, Finckh B, Nagel S, Nielsen P, Fischer R, Berger HM, Moison RM, Pichlmeier U, Kohlschu  ̈ tter B, Zander AR, Kohlschu  ̈ tter A. Impaired plasma antioxidative defense and increased nontransferrin- bound iron during high-dose chemotherapy and radioche- motherapy preceding bone marrow transplantation. Free Radic Biol Med 2000;28:887Á894.